Crossing the finish line at one Boston Marathon is a great accomplishment on its own, but one couple in Lake Placid has been ...

If you're looking for a state park to add to your bucket list, there's one in Vermont that houses a beautiful glacial feature ...

Despite lingering snow cover in some areas of the state, the Vermont Fish and Wildlife Department says anglers can still have ...

In downtown Saint Albans, Vermont, historic buildings rub elbows with new development projects as readily as new residents mingle with old-timers in Taylor Park. It’s a town that embraces its roots ...

Read on in our latest e-newsletter for a rundown of how road salt impacts infrastructure and how ice on Lake Champlain affects aquatic life. You can also get to know me a bit better, access our ...

Taxpayers are suing Arrowhead Union High School District officials, alleging misrepresentation in referendum information of renovation costs. The lawsuit claims the district has repeatedly sought ...

(Photo by Marco Franchina) A luxury Lake Arrowhead retreat equipped with an advanced Frontline wildfire sprinkler system is on the market for $5.5 million. This 4,448-square-foot home has been ...

Marlene Tromp, Ph.D., will become the University of Vermont’s 28th president, the university’s Board of Trustees announced today. She will formally assume the post later this summer. A humanities ...

The 2025 Lake Arrowhead Summer Concert Series is set to return, kicking off on Memorial Day weekend and running through Labor Day weekend. This year’s lineup features 33 concerts featuring the best ...

Karel Arrowhead, initially labelled as Sleeping Man in-game is an NPC in the Kuttenberg region of KCD2. However, he is only available to meet as a random event after the Speak of the Devil main ...

Around Vermont, those funding changes are affecting ... The agriculture industry is the largest contributor to Lake Champlain’s water quality problems, but farmers have also been responsible ...

On Monday, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic ...